#proteinassays

[immundnzltd]

A new study by Y. Finkel et al. published in the journal Nature reveals that SARS-CoV-2 RNA is bound to protein-making machines called ribosomes inside infected cells. Researchers have been able to identify 23 unannotated viral open reading frames (ORFs). These proteins might be controlling the production of known viral molecules.

If you need protein and immune assays to study proteins produced by SARS-CoV-2, Immundnz is here to help you. Contact our lab at [phone].

[immundnzltd]

We perform various immunologic and protein-based assays that are needed in your COVID-19 research or drug development. We use various methods like co-cultures, flow cytometry, ELISA, etc. for cell characterisation, cell lysate analysis, antibody applications, and more. Contact us: https://bit.ly/2N0ZdOa

[healthcare-industry-research]

[126 Pages Report] The protein assays market is expected to be valued at USD 1.42 Billion in 2017 and is projected to grow at a CAGR of 11.1% between 2017 and 2022, to reach USD 2.41 Billion in 2022.

Protein assays are used in life science research to determine the total protein concentration. Estimation of protein concentration is necessary for protein purification, electrophoresis, cell biology, molecular biology, and research applications.

[immundnzltd]

Immundnz understands the importance of assay design, target development, and high-throughput technologies in the early stages of drug discovery and development. We provide standard, customized, in vivo and ex vivo assays in immunology and protein biology for your product. Contact us for more info: https://www.immundnz.com

[healthcare-industry-research]

Global Protein Assays Research Industry to Witness Remarkable Growth in Next FIVE Years..!

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. This report also aims to provide insights into the global protein assays market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. Target Audience for this Report: # Protein assay manufacturers and vendors # Distributors of protein assays # Various research and consulting companies # Associations related to pharmaceutical and biotechnological research Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547 Factors Influencing Global Growth:- # Increasing Pharmaceutical and Biotech R&D Expenditure # Favorable Government Funding Scenario for Proteomics Research Restraints: # High Cost of Multiplex Assay Equipment # Sequestration Cuts in the U.S. Opportunities: # Emerging Markets # Biomarker Identification Challenges: # Dearth of Skilled Professionals # Issues Related to the Development of Protein Assays for Various Disease Types

Monetary Growth Expectations, Globally: The protein assays market is expected to be valued at USD 1.42 Billion in 2017 and is projected to grow at a CAGR of 11.1% between 2017 and 2022, to reach USD 2.41 Billion in 2022. Geographical Growth Scenario: Based on region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China, India, and Japan; the increasing R&D expenditure in life science, and increasing private-public partnerships for proteomics research are some major factors driving the growth of this regional segment. Read More: https://www.marketsandmarkets.com/PressReleases/protein-assay.asp Leading Market Players: # Thermo Fisher Scientific (U.S.) # Bio-Rad Laboratories, Inc. (U.S.) # Merck KGaA (Germany) # Cell Signaling Technology, Inc. (U.S.) # General Electric Company (U.S.) # PerkinElmer Inc. (U.S.). and many more…

The growth of the protein assays market can be attributed to the increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research. Based on the analysis of strategic developments undertaken by market players between 2014 and 2017, the key strategy followed by most companies in the market is expansions and agreements, partnerships, and collaborations. Thermo Fisher Scientific was leading player in the protein assay products market in 2016. The company focuses on organic and inorganic strategies in order to strengthen its position in the market. In 2015, the company acquired Alfa Aesar (U.S.), and in 2014 acquired Life Technology Corporation (U.S.) these acquisitions helped the company strengthen its protein assays product portfolio. In 2017, the company acquired Core Informatics (U.S.) and in 2016 acquired Affymetrix (U.S.) in order to enhance its share in the market. Merck KGaA was another leading player in the protein assay products market in 2016. It focuses mainly on collaborations, acquisitions, and expansions to strengthen its position in the market. In November 2015, the company acquired Sigma Aldrich (U.S.). This acquisition helped it to increase its product portfolio and its geographic presence. The company also focuses on expansions to strengthen its market share.